血管母细胞瘤的新疗法

Chaitanya Sanghadia, Melanie E. Martinez, Marisa McNulty, Eric Russ, Maxwell G. Woolridge, Dat Thanh Cao, Marko Micunovic, Jeffery Roberts, Juan Perez, Brandon Lucke-Wold
{"title":"血管母细胞瘤的新疗法","authors":"Chaitanya Sanghadia, Melanie E. Martinez, Marisa McNulty, Eric Russ, Maxwell G. Woolridge, Dat Thanh Cao, Marko Micunovic, Jeffery Roberts, Juan Perez, Brandon Lucke-Wold","doi":"10.37349/en.2023.00031","DOIUrl":null,"url":null,"abstract":"Hemangioblastoma are benign, vascularized cranial tumors caused by autosomal dominant inherited von Hippel-Lindau disease or can appear sporadically. This review will investigate current and emerging treatments for cerebral tumors. It will focus on the current and, more importantly, developing hemangioblastoma treatments. Surgical resectioning and radiotherapy are effective treatment options for cerebral tumors, whereas chemotherapies are not commonly used due to their limited ability to penetrate the blood-brain barrier. Recent chemotherapies have shown promise, but further research is needed to determine the efficacy as a treatment for hemangioblastomas. New advances in brachytherapy and immunotherapy are considered promising treatment options for hemangioblastoma. This review aims to offer valuable insights into the latest developments in hemangioblastoma treatments.","PeriodicalId":73001,"journal":{"name":"Exploration of neuroscience","volume":"17 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Emerging therapies of hemangioblastomas\",\"authors\":\"Chaitanya Sanghadia, Melanie E. Martinez, Marisa McNulty, Eric Russ, Maxwell G. Woolridge, Dat Thanh Cao, Marko Micunovic, Jeffery Roberts, Juan Perez, Brandon Lucke-Wold\",\"doi\":\"10.37349/en.2023.00031\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Hemangioblastoma are benign, vascularized cranial tumors caused by autosomal dominant inherited von Hippel-Lindau disease or can appear sporadically. This review will investigate current and emerging treatments for cerebral tumors. It will focus on the current and, more importantly, developing hemangioblastoma treatments. Surgical resectioning and radiotherapy are effective treatment options for cerebral tumors, whereas chemotherapies are not commonly used due to their limited ability to penetrate the blood-brain barrier. Recent chemotherapies have shown promise, but further research is needed to determine the efficacy as a treatment for hemangioblastomas. New advances in brachytherapy and immunotherapy are considered promising treatment options for hemangioblastoma. This review aims to offer valuable insights into the latest developments in hemangioblastoma treatments.\",\"PeriodicalId\":73001,\"journal\":{\"name\":\"Exploration of neuroscience\",\"volume\":\"17 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Exploration of neuroscience\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.37349/en.2023.00031\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Exploration of neuroscience","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.37349/en.2023.00031","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

血管母细胞瘤是由常染色体显性遗传的冯-希佩尔-林道病引起的良性、血管化颅脑肿瘤,也可偶发。本综述将探讨脑肿瘤的现有治疗方法和新兴治疗方法。它将重点关注目前的治疗方法,更重要的是正在开发的血管母细胞瘤治疗方法。手术切除和放射治疗是治疗脑肿瘤的有效方法,而化疗因其穿透血脑屏障的能力有限而不常用。最近的化疗方法显示出良好的前景,但要确定其作为治疗血管母细胞瘤的疗效,还需要进一步的研究。近距离放射治疗和免疫疗法的新进展被认为是治疗血管母细胞瘤的有前途的选择。本综述旨在就血管母细胞瘤治疗的最新进展提供有价值的见解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Emerging therapies of hemangioblastomas
Hemangioblastoma are benign, vascularized cranial tumors caused by autosomal dominant inherited von Hippel-Lindau disease or can appear sporadically. This review will investigate current and emerging treatments for cerebral tumors. It will focus on the current and, more importantly, developing hemangioblastoma treatments. Surgical resectioning and radiotherapy are effective treatment options for cerebral tumors, whereas chemotherapies are not commonly used due to their limited ability to penetrate the blood-brain barrier. Recent chemotherapies have shown promise, but further research is needed to determine the efficacy as a treatment for hemangioblastomas. New advances in brachytherapy and immunotherapy are considered promising treatment options for hemangioblastoma. This review aims to offer valuable insights into the latest developments in hemangioblastoma treatments.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信